Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Ophth. Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Ophth. Other
    Intravitreal Bevacizumab Can Stabilise Vision in Patients With Degenerative Eye Diseases: Presented at COS - (DGDispatch)
    Certain Clinical, Ultrasonographic Characteristics Can Assist in Diagnosing Uveal Melanoma: Presented at COS - (DGDispatch)
    FDA Approves Dexamethasone Intravitreal Implant for Macular Oedema - (DGNews)
    Ultra-Short Course of Subcutaneous Immunotherapy Well Tolerated in Patients With Seasonal Allergic Rhinoconjunctivitis: Presented at EAACI - (DGDispatch)
    Sublingual Immunotherapy Even More Effective During Pollen Peak Season in Children With Rhinoconjunctivitis: Presented at EAACI - (DGDispatch)

    News archive

     Recent webcasts/CME - Ophth. Other
      Treatment of Dry Eye
      Managing Age-Related Macular Degeneration - An Update
      Vision Problems in Older Adults, Part 2
      Vision Problems in Older Adults, Part 1
      Update on the Pathophysiology, Molecular Biology, and Treatment of Macular Edema

      Webcasts/CME archive

       Recent cases - Ophth. Other
        Bilateral Swollen Eyelids Occurring During Adjuvant Treatment with Tamoxifen for Early Breast Cancer
        Choroidopathy and Kidney Disease: A Case Report and Review of the Literature
        The Co-Occurrence of Toxocara Ocular and Visceral Larva Migrans Syndrome: A Case Series
        Merkel Cell Carcinoma Metastasis to the Iris in a 23 Year Old Female
        Unilateral Cotton Wool Spots: An Important Clue

        Cases archive
          




        my personal edition > ophth. other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Inhaled Steroid Can Lead To Increased Intra-Ocular Pressure In Children With Asthma: Presented at ESO

        By Cameron Johnston

        MADRID, SPAIN -- June 11, 2003 -- Using inhaled corticosteroids can cause a slight increase in intra-ocular pressure (IOP) in children with asthma, say researchers.

        And, while the increase is not large - only 1.2 mmHg on average - it is an accepted fact that every 1 mmHg increase in IOP increases a person's risk of glaucomatous damage to the optic nerve by 10%. For that reason, investigators recommend that regular eye examinations, including IOP measurements become standard practice for children whose asthma is being treated with inhaled corticosteroids.

        According to Dr. Evangelos Sioras, an ophthalmologist at the Triasio General Hospital, in Athens, the increased use of inhaled corticosteroids over the past decade has raised a number of issues for physicians and for patients, not the least of which is what effect these agents could have on a patient's eyes. It is well known, for example, that steroid use can lead to a transient increase in IOP among adults, but to date, no studies have been done in asthmatic children. He presented study findings here at the 14th congress of the European Society of Ophthalmology has reported.

        Although in this study, compliance on the part of the care-givers and the children themselves was a problem, Dr. Sioras said 15 children, mean age 10.6 years (range 6 to 14) underwent full ophthalmic investigations, including IOP measurements. In all, the children had 4 examinations, at 15 and 30 days after starting steroid treatment, and again at 15 and 30 days after treatment was suspended. The exact corticosteroid used was not important for the study, he said.

        The study results showed a mean difference in IOP of 1.2 mmHg from the time the young patients were on-treatment compared with when they were off-treatment. Mean IOP on-treatment was 13.95 mmHg, compared with 12.75 off-treatment. The odds ratio for an increase in IOP between the children being on-treatment or off-treatment was 1.35 (p=.01)

        Although this was a small study, Dr. Sioras said the results suggest that IOP should be monitored in asthmatic children who are using corticosteroids, and that more research is needed to determine the risk profile for children with asthma in terms of potential risk factors for damage to their eyes.

        Finally, he said, it might be useful for family practitioners who are dealing with longer term pediatric asthma patients to consult an ophthalmologist periodically to determine whether, or if damage is occurring in the young patient's eyes.


        [Study title: Ocular Hypertension Response To Inhaled And/Or Nasal Steroid Therapy For Asthma In Children. Abstract FP041]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send